{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:30Z","timestamp":1793400270382,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11154-022-09749-2","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T01:02:37Z","timestamp":1661216557000},"page":"1063-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-805X","authenticated-orcid":false,"given":"Kevin","family":"Perge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nicolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"9749_CR1","unstructured":"Naylor R, Knight Johnson A, del Gaudio D. Maturity-Onset Diabetes of the Young Overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al., editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500456\/. Accessed 20 Apr\u00a02020."},{"key":"9749_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","volume":"53","author":"BM Shields","year":"2010","unstructured":"Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53:2504\u20138.","journal-title":"Diabetologia"},{"key":"9749_CR3","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1210\/jc.2013-1279","volume":"98","author":"C Pihoker","year":"2013","unstructured":"Pihoker C, Gilliam LK, Ellard S, Dabelea D, Davis C, Dolan LM, et al. Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98:4055\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"9749_CR4","doi-asserted-by":"crossref","unstructured":"Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, et al. Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the UK pediatric diabetes population with monogenic diabetes. Diabetes Care. 2016;39:1879\u201388.","DOI":"10.2337\/dc16-0645"},{"key":"9749_CR5","doi-asserted-by":"crossref","unstructured":"Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation. N Engl J Med. Massachusetts Medical Society; 1998;338:226\u201330.","DOI":"10.1056\/NEJM199801223380404"},{"key":"9749_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1172\/JCI9804","volume":"106","author":"H Huopio","year":"2000","unstructured":"Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko H-L, Rahier J, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest. 2000;106:897\u2013906.","journal-title":"J Clin Invest"},{"key":"9749_CR7","unstructured":"Brusgaard K, Christesen HBT, Hansen T, Nj\u00f6lstad P, Malec J, Brock JB. A TCF1 mutation may cause transient congenital hyperinsulinism followed by MODY3. BioScientifica; 2006. https:\/\/www.endocrine-abstracts.org\/ea\/0011\/ea0011p283. Accessed 20 Apr\u00a02020."},{"issue":"4","key":"9749_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040118","volume":"4","author":"ER Pearson","year":"2007","unstructured":"Pearson ER, Boj SF, Steele AM, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 2007;4(4): e118.","journal-title":"PLoS Med"},{"key":"9749_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-34.","journal-title":"J Clin Epidemiol"},{"key":"9749_CR10","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1210\/jc.2004-0441","volume":"89","author":"SN Magge","year":"2004","unstructured":"Magge SN, Shyng S-L, MacMullen C, Steinkrauss L, Ganguly A, Katz LEL, et al. Familial Leucine-Sensitive Hypoglycemia of Infancy Due to a Dominant Mutation of the \u03b2-Cell Sulfonylurea Receptor. J Clin Endocrinol Metab. 2004;89:4450\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9749_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dc07-2059","volume":"31","author":"M Gussinyer","year":"2008","unstructured":"Gussinyer M, Clemente M, Cebri\u00e1n R, Yeste D, Albisu M, Carrascosa A. Glucose Intolerance and Diabetes Are Observed in the Long-Term Follow-Up of Nonpancreatectomized Patients With Persistent Hyperinsulinemic Hypoglycemia of Infancy Due to Mutations in the ABCC8 Gene. Diabetes Care. 2008;31:1257\u20139.","journal-title":"Diabetes Care"},{"key":"9749_CR12","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2337\/db08-0159","volume":"57","author":"M Abdulhadi-Atwan","year":"2008","unstructured":"Abdulhadi-Atwan M, Bushmann J, Tornovsky-Babaey S, Perry A, Abu-Libdeh A, Glaser B, et al. Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence. Diabetes. 2008;57:1935\u201340.","journal-title":"Diabetes"},{"key":"9749_CR13","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI35414","volume":"118","author":"SE Pinney","year":"2008","unstructured":"Pinney SE, MacMullen C, Becker S, Lin Y-W, Hanna C, Thornton P, et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest. 2008;118:2877\u201386.","journal-title":"J Clin Invest"},{"key":"9749_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1399-5448.2009.00626.x","volume":"11","author":"TC Vieira","year":"2010","unstructured":"Vieira TC, Bergamin CS, Gurgel LC, Mois\u00e9s RS. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation. Pediatr Diabetes. 2010;11:505\u20138.","journal-title":"Pediatr Diabetes"},{"key":"9749_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1515\/JPEM.2011.347","volume":"24","author":"G O\u00e7al","year":"2011","unstructured":"O\u00e7al G, Flanagan SE, Hacihamdio\u011flu B, Berbero\u011flu M, Siklar Z, Ellard S, et al. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8\/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell. J Pediatr Endocrinol Metab. 2011;24:1019\u201323.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"9749_CR16","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s00125-011-2207-4","volume":"54","author":"RR Kapoor","year":"2011","unstructured":"Kapoor RR, Flanagan SE, James CT, McKiernan J, Thomas AM, Harmer SC, et al. Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8\/KCNJ11 mutations. Diabetologia. 2011;54:2575\u201383.","journal-title":"Diabetologia"},{"key":"9749_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1297\/cpe.21.45","volume":"21","author":"A Saito-Hakoda","year":"2012","unstructured":"Saito-Hakoda A, Yorifuji T, Kanno J, Kure S, Fujiwara I. Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation. Clin Pediatr Endocrinol. 2012;21:45\u201352.","journal-title":"Clin Pediatr Endocrinol"},{"key":"9749_CR18","doi-asserted-by":"crossref","unstructured":"Harel S, Cohen ASA, Hussain K, Flanagan SE, Schlade-Bartusiak K, Patel M, et al. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture. J Pediatr Endocrinol Metab. 2015;28:345\u2013351.","DOI":"10.1515\/jpem-2014-0265"},{"key":"9749_CR19","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1515\/jpem-2017-0148","volume":"30","author":"A Dastamani","year":"2017","unstructured":"Dastamani A, G\u00fcemes M, Walker J, Shah P, Hussain K. Sirolimus precipitating diabetes mellitus in a patient with congenital hyperinsulinaemic hypoglycaemia due to autosomal dominant ABCC8 mutation. J Pediatr Endocrinol Metab. 2017;30:1219\u201322.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"9749_CR20","doi-asserted-by":"crossref","unstructured":"I\u015f\u0131k E, Demirbilek H, Houghton JA, Ellard S, Flanagan SE, Hussain K. Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation. J Clin Res Pediatr Endocrinol. 2019;11:82\u20137.","DOI":"10.4274\/jcrpe.galenos.2018.2018.0077"},{"key":"9749_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1515\/jpem.2011.083","volume":"24","author":"P Dus\u00e1tkov\u00e1","year":"2011","unstructured":"Dus\u00e1tkov\u00e1 P, Pr\u016fhov\u00e1 S, Sumn\u00edk Z, Kolouskov\u00e1 S, Obermannov\u00e1 B, Cinek O, et al. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes. J Pediatr Endocrinol Metab. 2011;24:377\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"9749_CR22","doi-asserted-by":"publisher","first-page":"E2026","DOI":"10.1210\/jc.2012-1356","volume":"97","author":"DE Stanescu","year":"2012","unstructured":"Stanescu DE, Hughes N, Kaplan B, Stanley CA, De Le\u00f3n DD. Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. 2012;97:E2026\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"9749_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/pedi.12655","volume":"19","author":"JY Tung","year":"2018","unstructured":"Tung JY, Boodhansingh K, Stanley CA, De Le\u00f3n DD. Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations. Pediatr Diabetes. 2018;19:910\u20136.","journal-title":"Pediatr Diabetes"},{"key":"9749_CR24","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s00125-007-0833-7","volume":"50","author":"SS Fajans","year":"2007","unstructured":"Fajans SS, Bell GI. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4\u03b1 (HNF4A). Diabetologia. 2007;50:2600\u20131.","journal-title":"Diabetologia"},{"key":"9749_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2337\/db07-1657","volume":"57","author":"RR Kapoor","year":"2008","unstructured":"Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, et al. Persistent Hyperinsulinemic Hypoglycemia and Maturity-Onset Diabetes of the Young Due to Heterozygous HNF4A Mutations. Diabetes. 2008;57:1659\u201363.","journal-title":"Diabetes"},{"key":"9749_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1479-828X.2009.01009.x","volume":"49","author":"JJ Conn","year":"2009","unstructured":"Conn JJ, Simm PJ, Oats JJN, Nankervis AJ, Jacobs SE, Ellard S, et al. Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A gene. Aust N Z J Obstet Gynaecol. 2009;49:328\u201330.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"9749_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1530\/EJE-09-0861","volume":"162","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, Kapoor RR, Mali G, Cody D, Murphy N, Schwahn B, et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol. 2010;162:987\u201392.","journal-title":"Eur J Endocrinol"},{"key":"9749_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jpeds.2011.01.003","volume":"158","author":"MM Pingul","year":"2011","unstructured":"Pingul MM, Hughes N, Wu A, Stanley CA, Gruppuso PA. Hepatocyte Nuclear Factor 4\u03b1 Gene Mutation Associated with Familial Neonatal Hyperinsulinism and Maturity-Onset Diabetes of the Young. J Pediatr. 2011;158:852\u20134.","journal-title":"J Pediatr"},{"key":"9749_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/BF03347074","volume":"34","author":"C Colombo","year":"2011","unstructured":"Colombo C, Geraci C, Suprani T, Pocecco M, Barbetti F. Macrosomia, transient neonatal hypoglycemia, and monogenic diabetes in a family with heterozygous mutation R154X of HNF4A gene. J Endocrinol Invest. 2011;34:252\u20133.","journal-title":"J Endocrinol Invest"},{"key":"9749_CR30","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1111\/dme.12369","volume":"31","author":"VB Arya","year":"2014","unstructured":"Arya VB, Rahman S, Senniappan S, Flanagan SE, Ellard S, Hussain K. HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response. Diabet Med. 2014;31:e11\u20135.","journal-title":"Diabet Med"},{"key":"9749_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/dme.12259","volume":"31","author":"SM McGlacken-Byrne","year":"2014","unstructured":"McGlacken-Byrne SM, Hawkes CP, Flanagan SE, Ellard S, McDonnell CM, Murphy NP. The evolving course of HNF4A hyperinsulinaemic hypoglycaemia\u2014a case series. Diabet Med. 2014;31:e1-5.","journal-title":"Diabet Med"},{"key":"9749_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.beem.2018.05.014","volume":"32","author":"S Galcheva","year":"2018","unstructured":"Galcheva S, Al-Khawaga S, Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia. Best Pract Res Clin Endocrinol Metab. 2018;32:551\u201373.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9749_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0378-3782(92)90135-4","volume":"29","author":"AL Fowden","year":"1992","unstructured":"Fowden AL. The role of insulin in fetal growth. Early Hum Dev. 1992;29:177\u201381.","journal-title":"Early Hum Dev"},{"key":"9749_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/ajmg.c.31737","volume":"181","author":"E Rosenfeld","year":"2019","unstructured":"Rosenfeld E, Ganguly A, Leon DDD. Congenital hyperinsulinism disorders: Genetic and clinical characteristics. Am J Med Genet C Semin Med Genet. 2019;181:682\u201392.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"9749_CR35","doi-asserted-by":"crossref","unstructured":"Guerin A, Nisenbaum R, Ray JG. Use of Maternal GHb Concentration to Estimate the Risk of Congenital Anomalies in the Offspring of Women with Prepregnancy Diabetes. Diabetes Care. American Diabetes Association. 2007;30:1920\u20135.","DOI":"10.2337\/dc07-0278"},{"key":"9749_CR36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-017-4206-6","volume":"60","author":"C Billionnet","year":"2017","unstructured":"Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60:636\u201344.","journal-title":"Diabetologia"},{"key":"9749_CR37","unstructured":"Gillis D. Familial Hyperinsulinism. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1375\/. Accessed 20 Apr\u00a02020"},{"key":"9749_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.earlhumdev.2010.05.003","volume":"86","author":"J-B Arnoux","year":"2010","unstructured":"Arnoux J-B, de Lonlay P, Ribeiro M-J, Hussain K, Blankenstein O, Mohnike K, et al. Congenital hyperinsulinism. Early Hum Dev. 2010;86:287\u201394.","journal-title":"Early Hum Dev"},{"key":"9749_CR39","doi-asserted-by":"publisher","unstructured":"G\u03cbemes M, Rahman SA, Kapoor RR, et al. Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management [published online ahead of print, 2020 Mar 17]. Rev Endocr Metab Disord. 2020.\u00a0https:\/\/doi.org\/10.1007\/s11154-020-09548-7.","DOI":"10.1007\/s11154-020-09548-7"},{"key":"9749_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1373\/clinchem.2007.098988","volume":"54","author":"AA Palladino","year":"2008","unstructured":"Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in Infancy and Childhood: When an Insulin Level Is Not Always Enough. Clin Chem Oxford Academic. 2008;54:256\u201363.","journal-title":"Clin Chem Oxford Academic"},{"key":"9749_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.beem.2013.06.005","volume":"27","author":"DD De Le\u00f3n","year":"2013","unstructured":"De Le\u00f3n DD, Stanley CA. Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Pract Res Clin Endocrinol Metab. 2013;27:763\u20139.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9749_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2015.09.045","volume":"168","author":"C Ferrara","year":"2016","unstructured":"Ferrara C, Patel P, Becker S, Stanley CA, Kelly A. Biomarkers of Insulin for the Diagnosis of Hyperinsulinemic Hypoglycemia in Infants and Children. J Pediatr. 2016;168:212\u20139.","journal-title":"J Pediatr"},{"key":"9749_CR43","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1210\/jc.2018-01613","volume":"103","author":"A Herrera","year":"2018","unstructured":"Herrera A, Vajravelu ME, Givler S, Mitteer L, Avitabile CM, Lord K, et al. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide. J Clin Endocrinol Metab. 2018;103:4365\u201372.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9749_CR44","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1530\/REP-14-0334","volume":"148","author":"N El Hajj","year":"2014","unstructured":"El Hajj N, Schneider E, Lehnen H, Haaf T. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauterine environment. Reproduction. 2014;148(6):R111\u201320.","journal-title":"Reproduction"},{"key":"9749_CR45","doi-asserted-by":"crossref","unstructured":"Steele AM, Wensley KJ, Ellard S, Murphy R, Shepherd M, Colclough K, et al. Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies. PLOS ONE. 2013;8:e65326.","DOI":"10.1371\/journal.pone.0065326"},{"key":"9749_CR46","doi-asserted-by":"crossref","unstructured":"Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab. Oxford Academic. 1995;80:386\u201392.","DOI":"10.1210\/jcem.80.2.7852494"},{"key":"9749_CR47","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2337\/diabetes.48.8.1652","volume":"48","author":"B Glaser","year":"1999","unstructured":"Glaser B, Ryan F, Donath M, Landau H, Stanley CA, Baker L, et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes. 1999;48:1652\u20137.","journal-title":"Diabetes"},{"key":"9749_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2337\/diabetes.50.2.329","volume":"50","author":"SG Straub","year":"2001","unstructured":"Straub SG, Cosgrove KE, \u00c4mm\u00e4l\u00e4 C, Shepherd RM, O\u2019Brien RE, Barnes PD, et al. Hyperinsulinism of Infancy: The Regulated Release of Insulin by KATP Channel\u2014Independent Pathways. Diabetes. 2001;50:329\u201339.","journal-title":"Diabetes"},{"key":"9749_CR49","doi-asserted-by":"publisher","first-page":"9270","DOI":"10.1074\/jbc.275.13.9270","volume":"275","author":"V Seghers","year":"2000","unstructured":"Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J. Sur1 Knockout Mice A model for KATP channel-independent regulation of insulin secretion. J Biol Chem. 2000;275:9270\u20137.","journal-title":"J Biol Chem"},{"key":"9749_CR50","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s00125-006-0367-4","volume":"49","author":"MS Remedi","year":"2006","unstructured":"Remedi MS, Rocheleau JV, Tong A, Patton BL, McDaniel ML, Piston DW, et al. Hyperinsulinism in mice with heterozygous loss of KATP channels. Diabetologia. 2006;49:2368\u201378.","journal-title":"Diabetologia"},{"key":"9749_CR51","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2337\/diabetes.49.8.1325","volume":"49","author":"SA Kassem","year":"2000","unstructured":"Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49:1325\u201333.","journal-title":"Diabetes"},{"key":"9749_CR52","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1530\/JME-15-0016","volume":"54","author":"SA Rahman","year":"2015","unstructured":"Rahman SA, Nessa A, Hussain K. Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol. 2015;54:R119\u201329.","journal-title":"J Mol Endocrinol"},{"key":"9749_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1172\/JCI115865","volume":"90","author":"RP Robertson","year":"1992","unstructured":"Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest. 1992;90:320\u20135.","journal-title":"J Clin Invest"},{"key":"9749_CR54","first-page":"1","volume":"3","author":"J Timsit","year":"2006","unstructured":"Timsit J, Bellann\u00e9-Chantelot C, Velho G. Diab\u00e8tes de type MODY. EMC Elsevier SAS. 2006;3:1\u20137.","journal-title":"EMC Elsevier SAS"},{"key":"9749_CR55","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1172\/JCI116596","volume":"92","author":"LK Olson","year":"1993","unstructured":"Olson LK, Redmon JB, Towle HC, Robertson RP. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest. 1993;92:514\u20139.","journal-title":"J Clin Invest"},{"key":"9749_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11892-021-01430-3","volume":"21","author":"A Petrelli","year":"2021","unstructured":"Petrelli A, Giovenzana A, Insalaco V, Phillips BE, Pietropaolo M, Giannoukakis N. Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes Endotypes. Curr Diab Rep. 2021;21:54.","journal-title":"Curr Diab Rep"},{"key":"9749_CR57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2337\/diacare.25.1.68","volume":"25","author":"J Weng","year":"2002","unstructured":"Weng J, Ekelund M, Lehto M, Li H, Ekberg G, Frid A, et al. Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes\u2013 Associated HLA Genotypes in Women With Gestational Diabetes Mellitus. Diabetes Care. 2002;25:68\u201371.","journal-title":"Diabetes Care"},{"key":"9749_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","volume":"55","author":"P Bowman","year":"2012","unstructured":"Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia. 2012;55:123\u20137.","journal-title":"Diabetologia"},{"key":"9749_CR59","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2337\/dc11-1243","volume":"35","author":"G Thanabalasingham","year":"2012","unstructured":"Thanabalasingham G, Pal A, Selwood MP, Dudley C, Fisher K, Bingley PJ, et al. Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young. Diabetes Care. 2012;35:1206\u201312.","journal-title":"Diabetes Care"},{"key":"9749_CR60","doi-asserted-by":"crossref","unstructured":"Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia. JAMA. 2014;311:279\u201386.","DOI":"10.1001\/jama.2013.283980"},{"key":"9749_CR61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","volume":"57","author":"A Stride","year":"2014","unstructured":"Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 2014;57:54\u20136.","journal-title":"Diabetologia"},{"key":"9749_CR62","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/dc14-2769","volume":"38","author":"AJ Chakera","year":"2015","unstructured":"Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S, et al. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation. Diabetes Care. 2015;38:1383\u201392.","journal-title":"Diabetes Care"},{"key":"9749_CR63","first-page":"166","volume":"60","author":"S Peter","year":"2003","unstructured":"Peter S. Acarbose and Idiopathic Reactive Hypoglycemia. HRP Karger Publishers. 2003;60:166\u20137.","journal-title":"HRP Karger Publishers"},{"key":"9749_CR64","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/humu.22279","volume":"34","author":"K Colclough","year":"2013","unstructured":"Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity-Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia. Hum Mutat. 2013;34:669\u201385.","journal-title":"Hum Mutat"},{"key":"9749_CR65","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2337\/db07-1742","volume":"57","author":"LW Harries","year":"2008","unstructured":"Harries LW, Locke JM, Shields B, Hanley NA, Hanley KP, Steele A, et al. The Diabetic Phenotype in HNF4A Mutation Carriers Is Moderated By the Expression of HNF4A Isoforms From the P1 Promoter During Fetal Development. Diabet Med. 2008;57:1745\u201352.","journal-title":"Diabet Med"},{"key":"9749_CR66","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/pedi.13333","volume":"23","author":"TI Hewat","year":"2022","unstructured":"Hewat TI, Laver TW, Houghton JAL, M\u00e4nnist\u00f6 JME, Alvi S, Brearey SP, et al. Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non-genetic risk factors in this group. Pediatr Diabetes. 2022;23:457\u201361.","journal-title":"Pediatr Diabetes"},{"key":"9749_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pedi.12192","volume":"15","author":"O Rubio-Cabezas","year":"2014","unstructured":"Rubio-Cabezas O, Hattersley AT, Nj\u00f8lstad PR, Mlynarski W, Ellard S, White N, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15:47\u201364.","journal-title":"Pediatr Diabetes"},{"key":"9749_CR68","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/dme.12992","volume":"33","author":"S Bacon","year":"2016","unstructured":"Bacon S, Kyithar MP, Rizvi SR, Donnelly E, McCarthy A, Burke M, et al. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A\u2013MODY cohort. Diabet Med. 2016;33:976\u201384.","journal-title":"Diabet Med"},{"key":"9749_CR69","doi-asserted-by":"crossref","unstructured":"Bacon S, Kyithar MP, Condron EM, Vizzard N, Burke M, Byrne MM. Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood. Acta Diabetol. 2016;53:965\u201372.","DOI":"10.1007\/s00592-016-0890-9"},{"key":"9749_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/1753-0407.12959","volume":"12","author":"A Haddouche","year":"2020","unstructured":"Haddouche A, Bellanne-Chantelot C, Rod A, Fournier L, Chiche L, Gautier J-F, et al. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. J Diabetes. 2020;12:48\u201357.","journal-title":"J Diabetes"},{"key":"9749_CR71","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2337\/dc19-0486","volume":"42","author":"MS GoodSmith","year":"2019","unstructured":"GoodSmith MS, Skandari MR, Huang ES, Naylor RN. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing. Diabetes Care. 2019;42:2247\u201355.","journal-title":"Diabetes Care"},{"key":"9749_CR72","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2337\/dc06-1744","volume":"30","author":"B Liljestr\u00f6m","year":"2007","unstructured":"Liljestr\u00f6m B, Tuomi T, Isomaa B, Sarelin L, Aktan-Collan K, K\u00e4\u00e4ri\u00e4inen H. Adolescents at Risk for MODY3 Diabetes Prefer Genetic Testing Before Adulthood. Diabetes Care. 2007;30:1571\u20133.","journal-title":"Diabetes Care"},{"key":"9749_CR73","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/dme.12742","volume":"32","author":"AR Bosma","year":"2015","unstructured":"Bosma AR, Rigter T, Weinreich SS, Cornel MC, Henneman L. A genetic diagnosis of maturity-onset diabetes of the young (MODY): experiences of patients and family members. Diabet Med. 2015;32:1385\u201392.","journal-title":"Diabet Med"},{"key":"9749_CR74","doi-asserted-by":"crossref","unstructured":"Kaffel N, Chakroun E, Dammak M, Mnif M, Smaoui M, Charfi N, et al. Inhibition paradoxale de\u00a0la\u00a0r\u00e9ponse somatotrope et\u00a0corticotrope \u00e0\u00a0l\u2019hypoglyc\u00e9mie par\u00a0hyperinsulinisme endog\u00e8ne: \u00e0\u00a0propos d\u2019une observation. Paradoxal growth hormone and cortisol response to hypoglycemia caused by endogenous hyperinsulinemia: a case report]. Ann Endocrinol (Paris). 2007;68:204\u20137.","DOI":"10.1016\/j.ando.2007.02.007"},{"key":"9749_CR75","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1210\/jc.2003-030135","volume":"88","author":"K Hussain","year":"2003","unstructured":"Hussain K, Hindmarsh P, Aynsley-Green A. Neonates with Symptomatic Hyperinsulinemic Hypoglycemia Generate Inappropriately Low Serum Cortisol Counterregulatory Hormonal Responses. J Clin Endocrinol. 2003;88:4342\u20137.","journal-title":"J Clin Endocrinol"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-022-09749-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-022-09749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:17:21Z","timestamp":1664255841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-022-09749-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["9749"],"URL":"https:\/\/doi.org\/10.1007\/s11154-022-09749-2","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"1 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}